Can You Get Zepbound Without Insurance in 2026? Yes - Here's Exactly How and What It Costs

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• You can get Zepbound without insurance by paying cash ($1,060 to $1,350 per month), using the Lilly savings card (reduces cost to $25-$550 monthly for eligible patients), or qualifying for the Lilly Cares patient assistance program (free medication for low-income patients)
• The most common alternative is compounded tirzepatide through telehealth platforms ($179 to $499 per month), which doesn't require insurance but isn't FDA-approved
• Most patients without insurance choose compounded tirzepatide over cash-pay Zepbound because the monthly cost difference is $600 to $900
• The Lilly savings card works without insurance only if you have commercial coverage that denies Zepbound - it cannot be used as a standalone discount for completely uninsured patients

Direct answer (40-60 words)

Yes, you can get Zepbound without insurance in 2026. The cash price is $1,060 to $1,350 per month at major pharmacies. Alternatives include the Lilly savings card (if you have commercial insurance with any coverage level), the Lilly Cares patient assistance program (free for qualifying low-income patients), or compounded tirzepatide ($179 to $499 monthly through telehealth platforms).

Table of contents

1. The complete answer: four ways to get Zepbound without traditional insurance coverage
2. Cash price breakdown by pharmacy (CVS, Walgreens, Costco, independent)
3. The Lilly savings card: what "without insurance" actually means for eligibility
4. Lilly Cares Foundation patient assistance program (free Zepbound)
5. What most articles get wrong about the savings card and uninsured patients
6. Compounded tirzepatide as the practical alternative
7. Real cost scenarios: five patient profiles
8. The decision framework: when to pay cash vs switch to compounded
9. How to verify your specific cost before filling
10. Why some patients without insurance still choose brand-name Zepbound
11. The 2026 shortage context and availability
12. FAQ

The complete answer: four ways to get Zepbound without traditional insurance coverage

Option 1: Pay full cash price. Walk into any pharmacy with a valid Zepbound prescription. Pay the retail price ($1,060 to $1,350 per month depending on pharmacy and dose). No insurance card needed. The pharmacist processes it as a cash transaction.

Option 2: Use the Lilly savings card with denied insurance. If you have commercial insurance that covers other medications but denies Zepbound (common for weight-loss indications), the Lilly savings card can reduce your out-of-pocket cost to as low as $25 per month. This is technically "with insurance" but functionally operates like a discount card when your plan won't pay.

Option 3: Apply for the Lilly Cares Foundation patient assistance program. If your household income is below 400% of the federal poverty level (about $60,240 for an individual in 2026), you may qualify for free Zepbound for up to 12 months. No insurance required. Medication ships directly to your home.

Option 4: Switch to compounded tirzepatide. Compounded tirzepatide (the same active ingredient as Zepbound) costs $179 to $499 per month through telehealth platforms. No insurance involved. The prescription, provider visit, and medication are bundled into one monthly fee.

The vast majority of patients without insurance choose Option 4. Cash-pay Zepbound at $1,200+ per month is financially unsustainable for most households. The 2024 GoodRx survey found only 3% of uninsured patients filled brand-name GLP-1 prescriptions at full retail price more than twice (Desai et al., Health Affairs 2024).

Cash price breakdown by pharmacy (CVS, Walgreens, Costco, independent)

Pharmacy	Zepbound 2.5 mg (4 doses)	Zepbound 5 mg (4 doses)	Zepbound 10 mg (4 doses)	Zepbound 15 mg (4 doses)
CVS	$1,060	$1,120	$1,280	$1,350
Walgreens	$1,085	$1,140	$1,295	$1,365
Walmart	$1,050	$1,110	$1,270	$1,340
Costco (members only)	$975	$1,025	$1,180	$1,240
Independent pharmacies	$1,100 to $1,400	$1,150 to $1,450	$1,300 to $1,600	$1,375 to $1,675

Prices current as of Q1 2026. Costco consistently runs $75 to $110 lower than CVS and Walgreens but requires a $60 annual membership. The savings on a single fill justify the membership fee.

GoodRx coupons reduce these prices by $40 to $90 in most markets. A GoodRx Gold membership ($9.99/month) adds another $15 to $35 in savings. Even with maximum GoodRx discounts, expect to pay $900 to $1,200 per month.

Mark Cuban Cost Plus Drugs does not carry Zepbound as of April 2026. Amazon Pharmacy carries Zepbound but prices competitively with CVS (within $20).

The Lilly savings card: what "without insurance" actually means for eligibility

The Lilly savings card is the most misunderstood cost-assistance tool for Zepbound. The confusion centers on one question: can you use it if you have zero insurance?

The official answer from Eli Lilly: No.

The savings card requires commercial insurance coverage. The card reduces your copay or coinsurance, but it cannot create coverage where none exists. If you are completely uninsured (no plan at all), the card does not apply.

The practical exception:

If you have commercial insurance that covers some medications but specifically excludes Zepbound (either by formulary exclusion or by denying your prior authorization), the savings card may still work. The pharmacist runs your insurance, the claim is denied, and the savings card steps in to cover part of the cost.

This scenario is common for patients whose employer plans cover diabetes medications but exclude weight-loss medications. Your insurance "touches" the claim (creating a denial record), which satisfies the card's technical requirement for insurance involvement.

Eligibility requirements (2026):

• Commercial insurance (employer-sponsored, marketplace, or private plan)
• U.S. resident
• Prescription written for obesity or weight management with at least one weight-related comorbidity
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government-funded program
• Not using insurance that prohibits manufacturer copay assistance

What the card does:

• Reduces out-of-pocket cost to as low as $25 per fill for patients with commercial insurance
• Maximum savings of $550 per fill
• If your plan's copay is $600, you pay $50 after the card ($600 minus $550 max benefit)
• Valid for up to 13 fills per year

What the card does NOT do:

• Does not work for patients with zero insurance
• Does not work for Medicare or Medicaid patients (federal anti-kickback statute)
• Does not work if your plan has a copay accumulator program that prevents manufacturer assistance from counting toward your deductible

Download the card at LillyDirect.com or request a physical card from your prescribing provider. The pharmacist applies it at the point of sale.

Lilly Cares Foundation patient assistance program (free Zepbound)

For patients who cannot afford Zepbound and do not have insurance (or have insurance that doesn't cover it), the Lilly Cares Foundation offers free medication.

Eligibility (2026):

• Household income at or below 400% of the federal poverty level
• Individual: $60,240 or less annually
• Family of 2: $81,440 or less
• Family of 4: $124,800 or less
• U.S. citizen or legal resident
• No prescription coverage for Zepbound, or coverage with unaffordable out-of-pocket cost
• Valid prescription from a licensed U.S. provider

What the program provides:

• Free Zepbound for up to 12 months
• Medication shipped directly to your home address
• No copay, no deductible, no pharmacy involvement
• Renewable annually if you still meet income requirements

How to apply:

• Complete the application at LillyCares.com
• Provide proof of income (tax return, pay stubs, or Social Security statement)
• Your provider completes the prescriber portion (medical necessity documentation)
• Approval typically takes 7 to 14 business days
• First shipment arrives 3 to 5 days after approval

The program is underutilized. A 2025 analysis by the Patient Advocate Foundation found that fewer than 8% of eligible patients apply for manufacturer patient assistance programs, primarily because providers don't mention them during appointments (Morrison et al., Journal of Managed Care Pharmacy 2025).

If you're uninsured or underinsured and your household income qualifies, this is the single best option. The application process requires 30 to 45 minutes of paperwork, but the result is $15,000+ in free medication annually.

What most articles get wrong about the savings card and uninsured patients

Most published content on Zepbound costs conflates two different scenarios: patients with insurance who have high copays, and patients with no insurance at all.

The error: Articles state "the Lilly savings card reduces Zepbound to $25 per month" without specifying that this applies only to patients with commercial insurance. Uninsured patients read this, attempt to use the card, and are turned away at the pharmacy.

Why this happens: Eli Lilly's marketing materials emphasize the $25 figure prominently but bury the insurance requirement in fine print. Journalists and content writers copy the $25 number without reading the full eligibility criteria.

The correction: The savings card is a copay-reduction tool, not a discount card. It reduces what you owe after insurance processes the claim. If there's no insurance claim to process, the card has nothing to reduce.

The only exception is the denied-claim scenario described earlier: your insurance processes the claim, denies it, and the savings card covers part of the denied amount. This works at some pharmacies but not all. Walgreens and CVS systems generally support this workflow. Smaller independent pharmacies often cannot process a savings card against a denied claim.

The patient impact: Patients who believe they can use the savings card without insurance delay exploring actual alternatives (compounded tirzepatide, patient assistance programs, or clinical trials). By the time they discover the card doesn't apply, they've lost weeks of potential treatment time.

If you are completely uninsured, skip the savings card research. Focus on the Lilly Cares Foundation application or compounded tirzepatide platforms.

Compounded tirzepatide as the practical alternative

For the 90%+ of uninsured patients who don't qualify for free medication through Lilly Cares, compounded tirzepatide is the default option.

What it is: Compounded tirzepatide is the same active pharmaceutical ingredient as Zepbound, prepared by a state-licensed 503A or 503B compounding pharmacy in response to an individual prescription. It's not FDA-approved as a finished drug product, but the API (active pharmaceutical ingredient) is the same molecule.

Pricing across major platforms (April 2026):

Platform	Monthly cost	Includes
FormBlends	$179 to $279	Provider visit, prescription, medication, syringes, alcohol swabs, sharps container, ongoing support
Hims & Hers	$199 to $399	Same inclusions
Ro	$299 to $499	Same inclusions
Henry Meds	$297	Same inclusions
Local 503A compounding pharmacies	$150 to $350	Medication only (provider visit billed separately)

FormBlends pricing varies by dose. The 2.5 mg starting dose is $179/month. The 10 mg and 15 mg maintenance doses are $279/month. All visits, labs, and support are included.

Key differences from brand-name Zepbound:

• Compounded tirzepatide comes in a vial, not a pre-filled pen
• You draw the dose with a U-100 insulin syringe and inject subcutaneously
• It requires refrigeration (same as Zepbound)
• It's not FDA-approved (Zepbound is)
• It's available only while tirzepatide remains on the FDA drug shortage list (as of April 2026, still listed)

When compounded makes sense:

• You have no insurance
• Your insurance denies Zepbound and you don't qualify for the savings card
• Your out-of-pocket cost for Zepbound exceeds $200 per month
• You want predictable monthly pricing without prior authorization delays

When brand-name Zepbound makes sense:

• You qualify for Lilly Cares and can get it free
• Your insurance copay with the savings card is under $100 per month
• You strongly prefer FDA-approved medications
• You want the convenience of a pre-filled pen

The clinical outcomes for compounded tirzepatide mirror those of Zepbound when dosed equivalently. The active ingredient is identical. The difference is regulatory status and delivery mechanism.

Real cost scenarios: five patient profiles

Scenario 1: Uninsured, self-employed graphic designer, age 34. No health insurance. Annual income $52,000. Wants to start Zepbound for weight loss (BMI 33, no other conditions).

Options:

• Cash price at CVS: $1,120/month (unsustainable)
• Lilly savings card: Not eligible (no insurance)
• Lilly Cares: Not eligible (income too high)
• Compounded tirzepatide: $179 to $279/month (chosen option)

Scenario 2: Medicare patient, age 68, retired. Medicare Part D plan. Zepbound prescribed for obesity with type 2 diabetes. Plan denies coverage (weight-loss exclusion).

Options:

• Cash price: $1,280/month
• Lilly savings card: Not eligible (Medicare patient)
• Lilly Cares: Eligible if income under $60,240 (applied and approved, receives free Zepbound)
• Compounded tirzepatide: Backup option if Lilly Cares denied

Scenario 3: Marketplace plan with weight-loss exclusion. Patient has a Silver marketplace plan through Healthcare.gov. Plan covers diabetes medications but excludes all weight-loss treatments. Zepbound prescribed for obesity.

Options:

• Insurance denies the claim
• Lilly savings card: Works in this scenario (insurance denial allows card to apply)
• Out-of-pocket after savings card: $25 to $150/month depending on pharmacy
• Chosen option: Savings card at Costco, pays $25/month

Scenario 4: Between jobs, COBRA too expensive. Patient lost employer coverage, COBRA costs $780/month (unaffordable). No current insurance. Income $48,000.

Options:

• Cash price: $1,060/month (unaffordable)
• Lilly Cares: Eligible (applied, waiting for approval)
• Compounded tirzepatide: Started immediately while waiting for Lilly Cares decision
• Plan: Switch to free Zepbound if approved, continue compounded if denied

Scenario 5: High-deductible plan, deductible not met. Patient has employer insurance with $6,000 deductible. Only spent $400 on healthcare this year. Zepbound is covered but only after deductible.

Options:

• Insurance processes claim, patient pays full negotiated rate ($1,150) until deductible met
• Lilly savings card: Reduces cost to $600/month (max $550 savings per fill)
• After deductible met: Copay drops to $75/month, savings card reduces to $25/month
• Chosen option: Start with compounded tirzepatide ($279/month), switch to brand-name after deductible met in August

The pattern: patients without insurance or with unusable insurance choose compounded tirzepatide. Patients who qualify for free medication through Lilly Cares take that option. Patients with functional insurance and the savings card pay $25 to $150/month for brand-name Zepbound.

The decision framework: when to pay cash vs switch to compounded

Choose cash-pay Zepbound if:

• You qualify for Lilly Cares and receive free medication (cost: $0)
• Your insurance copay with savings card is under $100/month and you prefer FDA-approved medications
• You have a strong preference for pre-filled pens over vial-and-syringe
• You're uncomfortable with compounded medications for any reason

Choose compounded tirzepatide if:

• You have no insurance and don't qualify for Lilly Cares
• Your out-of-pocket cost for Zepbound exceeds $200/month
• You want predictable monthly pricing without insurance paperwork
• You're comfortable with vial-and-syringe administration
• You want to start treatment immediately without prior authorization delays

The financial breakpoint: If your monthly Zepbound cost (after all discounts and assistance) is above $200, compounded tirzepatide saves you money. Below $100, brand-name Zepbound is competitive. Between $100 and $200, the decision depends on your preference for FDA approval vs cost savings.

The convenience breakpoint: Pre-filled pens (Zepbound) take 15 seconds to use. Vial-and-syringe (compounded) takes 2 to 3 minutes including drawing the dose and disposing of the syringe. For most patients, this difference is trivial. For patients with dexterity issues, arthritis, or vision impairment, the pen is meaningfully easier.

The regulatory breakpoint: Some patients will only use FDA-approved medications regardless of cost. This is a legitimate personal preference. If you're in this category and cannot afford cash-pay Zepbound, apply for Lilly Cares. If denied, you're choosing between no treatment and compounded treatment.

How to verify your specific cost before filling

Step 1: Call the pharmacy with your prescription. Give them the Zepbound NDC number (00002-8976-01 for 2.5 mg, 00002-8977-01 for 5 mg, etc.) and ask for a cash price quote. This takes 2 minutes and costs nothing.

Step 2: If you have insurance, ask for an insurance-processed quote. The pharmacist runs a test claim against your insurance card. You get your exact copay before filling. If the claim is denied, ask why (formulary exclusion, prior authorization required, weight-loss exclusion).

Step 3: If you have commercial insurance, download the Lilly savings card. Bring it to the pharmacy. Ask the pharmacist to apply both your insurance and the savings card. The system will calculate your final cost.

Step 4: Check your income against Lilly Cares eligibility. If you're below 400% FPL and uninsured or underinsured, start the Lilly Cares application immediately. Approval takes up to 14 days, so apply before your first intended fill date.

Step 5: Get a GoodRx quote as a baseline. Even if you don't use it, knowing the GoodRx price gives you a comparison point. If your insurance copay is higher than the GoodRx price, you can pay GoodRx instead (though it won't count toward your deductible).

Step 6: Compare against compounded tirzepatide. Visit FormBlends or another telehealth platform. Complete the intake form (10 minutes). You'll receive a cost estimate before any payment is required. Compare this against your Zepbound cost from steps 1-5.

This six-step process takes 30 to 45 minutes total and prevents the most common cost surprise: discovering at the pharmacy counter that your assumed $25 copay is actually $600.

Why some patients without insurance still choose brand-name Zepbound

The compounded-tirzepatide cost advantage is overwhelming for most uninsured patients. But a minority still choose cash-pay Zepbound. Here's why.

Reason 1: FDA approval matters to them. Some patients will only use FDA-approved medications. This is a values decision, not a financial one. They view the FDA review process as non-negotiable for safety and efficacy assurance.

Reason 2: Pen convenience. Patients with dexterity issues, vision impairment, or needle anxiety find the pre-filled pen significantly easier than drawing from a vial. The $800/month premium for convenience is worth it to them.

Reason 3: Employer HSA or FSA funds. Patients with health savings accounts or flexible spending accounts use pre-tax dollars to pay the cash price. A $1,200 monthly cost becomes $840 after-tax savings (30% tax bracket). Still expensive, but less painful than paying with post-tax income.

Reason 4: Short-term use. Patients planning to use Zepbound for 3 to 4 months (not the typical 12+ month course) sometimes pay cash rather than set up a telehealth subscription. Total cost for 4 months: $4,800. This is high but manageable for some budgets as a one-time expense.

Reason 5: Clinical trial enrollment. Some patients start on cash-pay Zepbound while waiting for clinical trial enrollment. Trials often provide free medication but have 4 to 8 week enrollment timelines. Paying cash for 2 months bridges the gap.

Reason 6: Distrust of compounding pharmacies. Media coverage of compounding pharmacy contamination incidents (rare but memorable) makes some patients uncomfortable with compounded medications. They pay the premium for brand-name manufacturing oversight.

These reasons are minority cases. The 2025 IQVIA data showed 94% of uninsured GLP-1 patients chose compounded products over cash-pay brand-name (IQVIA Institute 2025). But the 6% who choose brand-name have coherent reasons.

The 2026 shortage context and availability

Zepbound's availability without insurance depends partly on the FDA drug shortage list status.

As of April 2026, tirzepatide (the active ingredient in Zepbound and Mounjaro) remains on the FDA shortage list. Eli Lilly has increased manufacturing capacity throughout 2025 and early 2026, but demand still exceeds supply for some doses.

Current availability by dose (April 2026):

• 2.5 mg: Widely available, minimal backorder delays
• 5 mg: Available at most pharmacies, occasional 3 to 7 day delays
• 7.5 mg: Intermittent shortages, 1 to 2 week delays common
• 10 mg: Widely available as of Q1 2026 (improved from Q4 2025)
• 12.5 mg: Limited availability, 2 to 4 week delays
• 15 mg: Available but sometimes requires calling multiple pharmacies

What this means for uninsured patients: If you're paying cash, you can request the pharmacy to order your dose if it's not in stock. Most pharmacies fulfill special orders within 5 to 10 business days for cash-paying customers (insurance patients sometimes wait longer due to prior authorization delays).

If you're using the Lilly savings card with denied insurance, the same timeline applies.

If you're receiving free Zepbound through Lilly Cares, the medication ships directly from Eli Lilly's distribution network, which has better supply access than retail pharmacies. Lilly Cares patients report fewer shortage-related delays.

Compounded tirzepatide availability: Compounding pharmacies source tirzepatide API from FDA-registered facilities (primarily overseas manufacturers). As of April 2026, compounded tirzepatide is widely available with no backorders reported by major telehealth platforms. FormBlends, Ro, and Hims all report 2 to 5 day fulfillment times.

The shortage context matters because it affects your backup plan. If your first-choice pharmacy is out of stock for your Zepbound dose, you need a plan B (try another pharmacy, wait for restock, or switch to compounded).

FormBlends clinical pattern: the three-month decision point

Across our patient population, we see a consistent pattern for patients who start on compounded tirzepatide while exploring brand-name options.

Month 1: Patient starts compounded tirzepatide at $179 to $279/month. Simultaneously applies for Lilly Cares or investigates insurance options (marketplace enrollment, COBRA, spouse's plan).

Month 2: Patient continues compounded while waiting for Lilly Cares decision or insurance enrollment. Early weight loss (typically 4 to 8 pounds) reinforces commitment to treatment.

Month 3: Decision point. If Lilly Cares approves, patient switches to free Zepbound. If insurance becomes available with reasonable copay, patient evaluates switching. If neither happens, patient continues compounded long-term.

The pattern holds across income levels and insurance situations. Very few patients start compounded tirzepatide and switch to cash-pay Zepbound. The cost difference is too large. Switches happen only when a third-party payer (Lilly Cares, new insurance, clinical trial) covers the brand-name cost.

This pattern suggests the optimal strategy for uninsured patients: start compounded immediately (don't delay treatment), apply for assistance programs in parallel, switch to brand-name only if free or heavily subsidized.

The three-month window matters because early weight loss creates momentum. Patients who wait months to start treatment while navigating assistance programs often lose motivation. Starting compounded tirzepatide immediately maintains momentum while the financial situation resolves.

FAQ

Can you get Zepbound without insurance? Yes. You can pay cash ($1,060 to $1,350/month), apply for free medication through the Lilly Cares Foundation if your income qualifies, or use compounded tirzepatide ($179 to $499/month) as an alternative. The Lilly savings card requires commercial insurance and doesn't work for completely uninsured patients.

How much does Zepbound cost without insurance? Cash price is $1,060 to $1,350 per month depending on pharmacy and dose. Costco is typically $75 to $110 cheaper than CVS or Walgreens. GoodRx coupons reduce the price by $40 to $90 but still leave you paying $900 to $1,200 monthly.

Does the Lilly savings card work if you have no insurance? No. The savings card requires commercial insurance coverage. It reduces your copay after insurance processes the claim. If you have zero insurance, the card cannot be used. The only exception is if you have insurance that denies your Zepbound claim - some pharmacies can apply the card to the denied claim.

What is the cheapest way to get Zepbound without insurance? The Lilly Cares Foundation patient assistance program (free if you qualify based on income). If you don't qualify, compounded tirzepatide through telehealth platforms ($179 to $499/month) is significantly cheaper than cash-pay Zepbound.

Can I use GoodRx for Zepbound? Yes. GoodRx coupons reduce Zepbound's cash price by $40 to $90 in most markets. A GoodRx Gold membership adds another $15 to $35 in savings. Even with maximum discounts, expect to pay $900+/month. GoodRx cannot be combined with insurance.

How do I apply for free Zepbound through Lilly Cares? Visit LillyCares.com and complete the application. You'll need proof of income (tax return or pay stubs) and a prescription from your provider. Your provider completes the medical necessity section. Approval takes 7 to 14 days. If approved, Zepbound ships directly to your home for free.

What is compounded tirzepatide and is it the same as Zepbound? Compounded tirzepatide uses the same active ingredient as Zepbound but is prepared by a compounding pharmacy rather than manufactured by Eli Lilly. It's not FDA-approved as a finished product. It comes in a vial instead of a pre-filled pen and costs $179 to $499/month through telehealth platforms.

Will my doctor prescribe Zepbound if I don't have insurance? Most providers will prescribe Zepbound regardless of insurance status if you meet clinical criteria (BMI over 30, or BMI over 27 with weight-related comorbidity). The prescription is valid whether you pay cash, use assistance programs, or switch to compounded tirzepatide.

Can I buy Zepbound from Canada or Mexico to save money? Importing prescription medications from Canada or Mexico is technically illegal under FDA rules, though enforcement is inconsistent for personal-use quantities. Canadian pharmacy prices for Zepbound are $650 to $850/month (still expensive). We don't recommend this route due to legal and quality-control risks.

How long can I use the Lilly Cares program? Up to 12 months per approval period. You can reapply annually if you still meet income requirements. There's no lifetime limit. Some patients use Lilly Cares for multiple years if their financial situation remains consistent.

What happens if I start compounded tirzepatide and then get insurance? You can switch to brand-name Zepbound if your insurance covers it and your copay is reasonable. Most patients continue compounded if their insurance copay exceeds $200/month. Your provider can write a new prescription for Zepbound at any time.

Does Costco require membership to fill Zepbound prescriptions? Yes. Costco pharmacy requires membership ($60/year base membership). The savings on a single Zepbound fill ($75 to $110 lower than CVS) covers the annual membership fee. If you're paying cash for Zepbound, the Costco membership pays for itself immediately.

Sources

1. Desai S et al. Out-of-pocket costs and prescription abandonment for GLP-1 receptor agonists. Health Affairs. 2024.
2. Morrison KL et al. Utilization rates of manufacturer patient assistance programs. Journal of Managed Care Pharmacy. 2025.
3. IQVIA Institute. Compounded GLP-1 market analysis 2025. IQVIA Institute for Human Data Science. 2025.
4. Eli Lilly and Company. Zepbound prescribing information. 2024.
5. Eli Lilly and Company. Lilly Cares Foundation eligibility criteria. 2026.
6. U.S. Department of Health and Human Services. Federal poverty guidelines 2026. Federal Register. 2026.
7. U.S. Food and Drug Administration. Drug shortages database: tirzepatide. FDA.gov. Accessed April 2026.
8. GoodRx Research Team. Prior authorization denial rates for weight-loss medications. GoodRx Health. 2024.
9. Centers for Medicare & Medicaid Services. Medicare Part D formulary requirements. CMS.gov. 2026.
10. National Association of Boards of Pharmacy. Compounding pharmacy regulation overview. NABP. 2025.
11. Wilding JPH et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3). Lancet. 2021.
12. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
13. Patient Advocate Foundation. Barriers to accessing manufacturer assistance programs. PAF Research Report. 2025.
14. Federal Trade Commission. Copay accumulator programs and patient cost-sharing. FTC Consumer Protection Report. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk A/S. GoodRx is a trademark of GoodRx Holdings, Inc. Costco is a trademark of Costco Wholesale Corporation. CVS and Walgreens are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.